Search

Author/Creator Gurrell, Ian

1. A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. Issue 10 (October 2019)

Authors:
Thom, George; Tian, Mei-Mei; Hatcher, Jon P; Rodrigo, Natalia; Burrell, Matthew; Gurrell, Ian; Vitalis, Timothy Z; Abraham, Thomas; Jefferies, Wilfred A; Webster, Carl I; Gabathuler, Reinhard
Journal:
Journal of cerebral blood flow & metabolism
Issue:
Volume 39:Issue 10(2019)
Page Start:
2074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine. (December 2020)

Authors:
Kopruszinski, Caroline M; Thornton, Peter; Arnold, Joanne; Newton, Philip; Lowne, David; Navratilova, Edita; Swiokla, Juliana; Dodick, David W; Dobson, Claire; Gurrell, Ian; Chessell, Iain Patrick; Porreca, Frank
Journal:
Cephalalgia
Issue:
Volume 40:Number 14(2020)
Page Start:
1535
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system. Issue 2 (17th February 2018)

Authors:
Thom, George; Hatcher, Jon; Hearn, Arron; Paterson, Judy; Rodrigo, Natalia; Beljean, Arthur; Gurrell, Ian; Webster, Carl
Journal:
MAbs
Issue:
Volume 10:Issue 2(2018)
Page Start:
304
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗